Biomarkers like kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin (NGAL) reflect tubular injury but overlook platelet-driven immune activation, a key contributor to DKD progression. This evidence concerns the gene LCN2 and diabetic kidney disease.